Literature DB >> 22276975

Iron(III) protoporphyrin IX complexes of the antimalarial Cinchona alkaloids quinine and quinidine.

Katherine A de Villiers, Johandie Gildenhuys, Tanya le Roex.   

Abstract

The antimalarial properties of the Cinchona alkaloids quinine and quinidine have been known for decades. Surprisingly, 9-epiquinine and 9-epiquinidine are almost inactive. A lack of definitive structural information has precluded a clear understanding of the relationship between molecular structure and biological activity. In the current study, we have determined by single crystal X-ray diffraction the structures of the complexes formed between quinine and quinidine and iron(III) protoporphyrin IX (Fe(III)PPIX). Coordination of the alkaloid to the Fe(III) center is a key feature of both complexes, and further stability is provided by an intramolecular hydrogen bond formed between a propionate side chain of Fe(III)PPIX and the protonated quinuclidine nitrogen atom of either alkaloid. These interactions are believed to be responsible for inhibiting the incorporation of Fe(III)PPIX into crystalline hemozoin during its in vivo detoxification. It is also possible to rationalize the greater activity of quinidine compared to that of quinine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22276975     DOI: 10.1021/cb200528z

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  19 in total

1.  Design, Synthesis and Evaluation of Bifunctional Acridinine-Naphthalenediimide Redox-Active Conjugates as Antimalarials.

Authors:  Srikanta Dana; Sudhir Kumar Keshri; Jyoti Shukla; Kunwar Somesh Vikramdeo; Neelima Mondal; Pritam Mukhopadhyay; Suman Kumar Dhar
Journal:  ACS Omega       Date:  2016-09-01

2.  Artemisinin-Based Drugs Target the Plasmodium falciparum Heme Detoxification Pathway.

Authors:  Kaleab A Ribbiso; Laura E Heller; Abigail Taye; Erin Julian; Andreas V Willems; Paul D Roepe
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

3.  Bayesian models trained with HTS data for predicting β-haematin inhibition and in vitro antimalarial activity.

Authors:  Kathryn J Wicht; Jill M Combrinck; Peter J Smith; Timothy J Egan
Journal:  Bioorg Med Chem       Date:  2014-12-20       Impact factor: 3.641

4.  The single crystal X-ray structure of β-hematin DMSO solvate grown in the presence of chloroquine, a β-hematin growth-rate inhibitor.

Authors:  Johandie Gildenhuys; Tanya le Roex; Timothy J Egan; Katherine A de Villiers
Journal:  J Am Chem Soc       Date:  2013-01-09       Impact factor: 15.419

Review 5.  Hemozoin and antimalarial drug discovery.

Authors:  Kim Y Fong; David W Wright
Journal:  Future Med Chem       Date:  2013-08       Impact factor: 3.808

6.  Identification and SAR Evaluation of Hemozoin-Inhibiting Benzamides Active against Plasmodium falciparum.

Authors:  Kathryn J Wicht; Jill M Combrinck; Peter J Smith; Roger Hunter; Timothy J Egan
Journal:  J Med Chem       Date:  2016-06-24       Impact factor: 7.446

7.  Mutation in the Plasmodium falciparum CRT protein determines the stereospecific activity of antimalarial cinchona alkaloids.

Authors:  Carol E Griffin; Jonathan M Hoke; Upeka Samarakoon; Junhui Duan; Jianbing Mu; Michael T Ferdig; David C Warhurst; Roland A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191

8.  To kill or not to kill, that is the question: cytocidal antimalarial drug resistance.

Authors:  Paul D Roepe
Journal:  Trends Parasitol       Date:  2014-02-13

9.  Antimalarial efficacy of hydroxyethylapoquinine (SN-119) and its derivatives.

Authors:  Natalie G Sanders; David J Meyers; David J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

10.  Intrinsic fluorescence properties of antimalarial pyrido[1,2-a]benzimidazoles facilitate subcellular accumulation and mechanistic studies in the human malaria parasite Plasmodium falciparum.

Authors:  Constance M Korkor; Larnelle F Garnie; Leah Amod; Timothy J Egan; Kelly Chibale
Journal:  Org Biomol Chem       Date:  2020-11-04       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.